Drug
Antimony Sodium Gluconate clinical trials
Also written sodium stibogluconate.
A product of Antimony; its studies count on that page too.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 8
U.S. Army Medical Research and Development Command (2) · Case Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Sarder Patel Medical College (1) · The Cleveland Clinic (1) · Northwestern University (1) · First Affiliated Hospital of Jinan University (1)
Often tested with
Tested in the same studies.
Cisplatin (1) · Dacarbazine (1) · Vinblastine (1) · Interferon alpha-2 (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Antimony
Studies
Open first, then newest update. How each study uses Antimony Sodium Gluconate is read from its arms, and is right about nine times in ten.
Testing it · 8
- Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 MutationsStatus unknownPhase 2First Affiliated Hospital of Jinan UniversityNCT04906031Written as Sodium stibogluconate
- Sodium Stibogluconate Treatment of LeishmaniasisCompletedPhase 2U.S. Army Medical Research and Development CommandNCT00662012Written as Sodium Stibogluconate (SSG)
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedPhase 1Case Comprehensive Cancer CenterNCT00498979Written as sodium stibogluconate
- Use of Sodium Stibogluconate as a Treatment for LeishmaniasisCompletedPhase 1/2U.S. Army Medical Research and Development CommandNCT00657618Written as Sodium Stibogluconate (SSG)
- Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesCompletedPhase 1M.D. Anderson Cancer CenterNCT00629200Written as Sodium Stibogluconate
- Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or MyelomaTerminatedPhase 1The Cleveland ClinicNCT00311558Written as sodium stibogluconate
- Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic SyndromeTerminatedPhase 1Northwestern UniversityNCT01009502Written as sodium stibogluconate
- Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in IndiaCompletedPhase 4Sarder Patel Medical CollegeNCT01661296Written as Sodium stibogluconate
As the comparator · 9 — what is tested is compared with Antimony Sodium Gluconate
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingPhase 3Institute of Tropical Medicine, BelgiumNCT07463040Written as Sodium Stibogluconate (SSG)
- Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateRecruitingPhase 2Al-Mustafa University CollegeNCT06798402Written as sodium stibogluconate (Pentostam)
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingPhase 3Zagazig UniversityNCT05708625Written as Intralesional Sodium stibogluconate
- LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept StudyCompletedPhase 2Drugs for Neglected DiseasesNCT05957978Written as sodium stibogluconate
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaCompletedPhase 3Drugs for Neglected DiseasesNCT03129646Written as Sodium stibogluconate
- Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous LeishmaniasisCompletedPhase 2U.S. Army Medical Research and Development CommandNCT00884377Written as Sodium stibogluconate (Pentostam)
- Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V LeishmaniasisCompletedPhase 3Drugs for Neglected DiseasesNCT00255567Written as Sodium Stibogluconate
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous LeishmaniasisCompletedPhase 2Access to Advanced Health Institute (AAHI)NCT01011309Written as Sodium stibogluconate
- Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis PatientsCompletedPhase 2Waisenmedizin e. V. Promoting Access to Essential MedicineNCT00996463Written as Sodium Stibogluconate
Codes
What other systems call Antimony Sodium Gluconate · ClinicalTrials.gg INT007008
- MeSH (NLM) D000967Antimony Sodium GluconateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) V083S0159DSODIUM STIBOGLUCONATE ANHYDROUSConfirmed FDA, NLM
- RxNorm 8010One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000967 | Antimony Sodium Gluconate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | V083S0159D | SODIUM STIBOGLUCONATE ANHYDROUS | Confirmed FDA, NLM |
| RxNorm | 8010 | — | One source FDA |
Also registered as sodium stibogluconate nonahydrate (UNII APJ6285Y89).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.